|
||
Cancer
- Cancer PHGKB -
What's New
Last Posted: Oct 23, 2019
- Choosing wisely: Selecting PARP inhibitor combinations to promote anti-tumor immune responses beyond BRCA mutations.
Veneris Jennifer Taylor et al. Gynecologic oncology 2019 Oct - Mapping genetic interactions in cancer: a road to rational combination therapies
B Tutuncioglu et al, Genome Medicine, October 22, 2019 - Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report
MD Valentin et al, Hereditary Cancer in Clinical Practice, October 2019 - Enhancing Observational Data Collection to Inform Precision Cancer Research and Care
DCCPS, NCI, October 2019 - The Colorectal Cancer Risk Assessment Tool
NCI, 2019 - Blending Insights from Implementation Science and the Social Sciences to Mitigate Inequities in Screening for Hereditary Cancer Syndromes
L Senier et al, MDPI, JPM, October 2019 - BRCA1/2 Genetic Testing Recommendations Still Leave Issues Unresolved
U Penn Medicine, 2019 - A systems approach to clinical oncology uses deep phenotyping to deliver personalized care
JT Yurkovich et al, Nature Rev Oncology, October 2019 - What Beyonce’s Dad And Angelina Jolie Have In Common
E Matloff, Forbes, October 18, 2019 - Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
J Tie et al, JAMA Oncology, October 17, 2019 - Cost-effectiveness of risk-stratified colorectal cancer screening based on polygenic risk – current status and future potential
SK Naber et al, JNCI SPectrum, October 17, 2019 - Beyoncé’s Dad Has a Mutation More African-Americans Should Be Tested For An inherited gene that can be discovered early caused Matthew Knowles’s breast cancer.
E Stallings, NY Times, October 16, 2019 - Precision medicine in pancreatic cancer: treating every patient as an exception.
Herbst Brian et al. The lancet. Gastroenterology & hepatology 2019 Oct (10) 805-810 - Exome Sequencing Reveals a High Prevalence of BRCA1 and BRCA2 Founder Variants in a Diverse Population-Based Biobank
NS Abul-Husn et al, BioRXIV, October 13, 2019 - Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients.
Peters Brandilyn A et al. Genome medicine 2019 Oct (1) 61
Content Summary
- CDC Information (103)
- NIH Information (225)
- CDC Genomics Publications (133)
- Human Genome Epidemiologic Studies (39862)
- GWAS Studies (576)
- Human Genomics Translation/Implementation Studies (4261)
- Genomic Tests Evidence Synthesis (493)
- Genomic Tests Guidelines (306)
- Tier-Classified Guidelines (179)
- Non-Genomics Precision Health (249)
- Pathogen Advanced Molecular Detection (173)
- State Public Health Genomics Programs (192)
- Reviews/Commentaries (3284)
- Tools/Methods (149)
- Ethical/Legal and Social Issues (ELSI) (131)
Common Type
Quick Links to Other Resources
About Cancer PHGKB
Cancer PHGKB is an online, continuously updated, searchable database...detail
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Jul 30, 2019
- Page last updated:Oct 23, 2019
- Content source: